Medical shop sealed for illegal sale of psychotropic drugs
UDHAMPUR: A joint team of officials from the Drug and Food Control Organisation Udhampur and the Police Department conducted regulatory inspections and sealed a medical shop for illegal sale of…
Popular diabetes drug, Mounjaro, launched in India
Mounjaro (tirzepatide): A breakthrough drug for the treatment of Type 2 diabetes and obesity, has been released in India. The drug has been approved by the Central Drugs Standard Control Organization…
Pharma industry says UK pricing revenue unsustainable, blocking investments
The pharmaceutical industry on Thursday blasted the UK government’s levy that aims to curb the national health system’s drugs bill, arguing it is unsustainable and is halting companies from making…
Marksans Pharma Goa facility gets Australian nod to manufacture pharma formulations for Australian markets
Mumbai: Marksans Pharma Limited has announced that its manufacturing facility located at Plot A-1, Phase 1-A, Verna Industrial Estate, Verna, Goa has been approved by Australian TGA for manufacture of…
DCA officials seize spurious Montek-LC tablets, raid a quack’s clinic and seize misleading ayurvedic medicine
HYDERABAD: Officials of Drugs Control Administration, Telangana, seized Spurious Drugs (Counterfeit Versions) ‘Montek-LC’ Tablets (Montelukast Sodium and Levocetirizine Hydrochloride Tablets), falsely claimed to be manufactured by Sun Pharma Laboratories Ltd.…
Patanjali’s study on Renogrit, that fights cancer drug-induced kidney damage, among 2024’s most notable research papers
A research paper published on Patanjali’s Renogrit, a formulation that is effective against cancer drug cisplatin’s damaging effect on kidneys, has been featured among the most notable research studies of 2024.…
Strides Pharma approves demerger from Arco Labs
Strides Pharma is set to demerge from Arco Labs, a global capability centre, the company said in its exchange filing on Wednesday. Board of Directors of Strides Pharma Science Limited (Strides) and Arco…
Milestone Pharma Expands Sale Agreement, Increases Offering
Milestone Pharmaceuticals Inc. (NASDAQ:MIST), a pharmaceutical company specializing in cardiovascular treatments with a market capitalization of $155.39 million, has amended its sales agreement with Jefferies LLC, effectively increasing its common…
Novo Nordisk regains membership in UK pharma body
London: Danish pharmaceutical giant Novo Nordisk has regained its membership in the UK’s pharmaceutical industry body after serving a two-year suspension for breaching a national drugmakers practice code. The Association of the British…
USV Joins Empagliflozin generic contest, launches its brand Xenia
New Delhi: One of India’s leading anti-diabetic players, USV, has become the latest entrant in the Empagliflozin generic contest with the launch of its version, Xenia, in India. The Indian drug maker…
